text
"['\n2. 연결재무제표\n2-1. 연결 재무상태표\n연결 재무상태표\n제 19 기 \xa0 \xa0 \xa0 \xa0 \xa02023.12.31 현재\n제 18 기 \xa0 \xa0 \xa0 \xa0 \xa02022.12.31 현재\n제 17 기 \xa0 \xa0 \xa0 \xa0 \xa02021.12.31 현재\n(단위 : 백만원)\n\u3000\n제 19 기\n제 18 기\n제 17 기\n자산\n\u3000\n\u3000\n\u3000\n\u3000현금 및 예치금\n34,480,458\n45,840,351\n31,406,596\n\u3000당기손익-공정가치측정 금융자산\n54,605,832\n52,374,699\n38,718,285\n\u3000기타포괄손익-공정가치측정 금융자산\n44,313,496\n37,779,945\n39,473,529\n\u3000상각후원가측정 유가증권\n36,480,396\n38,928,911\n23,769,017\n\u3000상각후원가측정 대출채권\n381,410,658\n361,495,530\n337,349,273\n\u3000위험회피회계파생상품자산\n9,678\n32,312\n77,507\n\u3000관계기업 및 공동기업 투자주식\n4,159,967\n3,917,787\n3,282,042\n\u3000보험계약자산\n7,718\n2,826\n\u3000\n\u3000재보험계약자산\n42,203\n33,030\n\u3000\n\u3000유형자산\n6,505,642\n5,243,039\n3,539,669\n\u3000투자부동산\n1,321,579\n1,250,085\n1,055,719\n\u3000무형자산\n935,122\n803,949\n748,337\n\u3000순확정급여자산\n58,648\n134,965\n\u3000\n\u3000이연법인세자산\n364,438\n396,364\n302,030\n\u3000당기법인세자산\n63,279\n42,144\n27,515\n\u3000매각예정비유동자산\n57,643\n72,950\n412,594\n\u3000기타자산\n27,109,238\n20,254,393\n22,283,157\n\u3000자산총계\n591,925,995\n568,603,280\n502,445,270\n자본과 부채\n\u3000\n\u3000\n\u3000\n\u3000부채\n\u3000\n\u3000\n\u3000\n\u3000\u3000당기손익-공정가치측정 금융부채\n21,599,202\n28,020,558\n15,876,923\n\u3000\u3000예수부채\n371,866,240\n362,575,964\n325,149,095\n\u3000\u3000차입부채\n43,590,349\n37,087,312\n30,261,598\n\u3000\u3000사채\n58,702,329\n56,673,832\n54,476,161\n\u3000\u3000위험회피회계파생상품부채\n432,303\n546,408\n118,599\n\u3000\u3000보험계약부채\n5,546,506\n5,389,087\n\u3000\n\u3000\u3000재보험계약부채\n6,701\n6,222\n\u3000\n\u3000\u3000순확정급여부채\n175,899\n10,610\n198,020\n\u3000\u3000충당부채\n841,636\n636,761\n587,422\n\u3000\u3000이연법인세부채\n363,510\n2,259\n203,288\n\u3000\u3000당기법인세부채\n134,109\n728,386\n782,822\n\u3000\u3000기타부채\n48,485,494\n39,297,733\n39,292,002\n\u3000\u3000부채총계\n551,744,278\n530,975,132\n466,945,930\n\u3000자본\n\u3000\n\u3000\n\u3000\n\u3000\u3000지배기업소유주지분\n39,343,318\n36,635,712\n34,218,635\n\u3000\u3000\u3000자본금\n1,501,210\n1,501,210\n1,501,210\n\u3000\u3000\u3000신종자본증권\n3,606,048\n3,294,688\n2,626,459\n\u3000\u3000\u3000자본잉여금\n10,582,774\n10,581,291\n10,576,587\n\u3000\u3000\u3000자본조정\n(181,682)\n(165,041)\n(315,606)\n\u3000\u3000\u3000기타포괄손익누계액\n(1,291,177)\n(1,762,964)\n(994,227)\n\u3000\u3000\u3000이익잉여금\n25,126,145\n23,186,528\n20,824,212\n\u3000\u3000비지배지분\n838,399\n992,436\n1,280,705\n\u3000\u3000자본총계\n40,181,717\n37,628,148\n35,499,340\n\u3000부채및자본총계\n591,925,995\n568,603,280\n502,445,270\n(주1) 2023년 1월 1일부터 국제보험회계기준 IFRS17을 최초 적용함에 따라 제18(전)기 연결재무제표는 재작성되었습니다. 전환일은 2022년 1월 1일 입니다. 구체적인 내용은 III. 재무에 관한 사항 8. 기타 재무에 관한 사항 ""가. 재무제표 재작성 등 유의사항""을 참고하시기 바랍니다.\n(주2) 제17(전전)기 연결재무제표는 IFRS17을 미적용한 금액입니다.\n(주3) 제19기(당기) 재무제표는 주주총회 승인전 재무제표이며, 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.\n2-2. 연결 포괄손익계산서\n연결 포괄손익계산서\n제 19 기 2023.01.01 부터 2023.12.31 까지\n제 18 기 2022.01.01 부터 2022.12.31 까지\n제 17 기 2021.01.01 부터 2021.12.31 까지\n(단위 : 백만원)\n\u3000\n제 19 기\n제 18 기\n제 17 기\n순이자이익\n8,879,449\n9,006,015\n7,437,205\n\u3000이자수익\n23,275,944\n15,984,691\n10,867,491\n\u3000\u3000기타포괄손익-공정가치측정 및 상각후원가 측정 금융상품 이자수익\n22,424,686\n15,417,542\n\u3000\n\u3000\u3000당기손익-공정가치측정 금융상품 이자수익\n851,106\n468,479\n\u3000\n\u3000\u3000보험 및 재보험계약 이자수익\n152\n98,670\n\u3000\n\u3000이자비용\n(14,396,495)\n(6,978,676)\n(3,430,286)\n\u3000\u3000금융상품 이자비용\n(14,066,014)\n(6,959,006)\n\u3000\n\u3000\u3000보험 및 재보험계약 이자비용\n(330,481)\n(19,670)\n\u3000\n순수수료이익\n1,977,733\n1,715,071\n1,741,717\n\u3000수수료수익\n3,034,920\n2,688,951\n2,653,186\n\u3000수수료비용\n(1,057,187)\n(973,880)\n(911,469)\n당기손익-공정가치측정 금융상품 관련 순손익\n745,788\n126,234\n789,984\n기타포괄손익-공정가치측정 금융자산관련순손익\n80,582\n17,146\n104,548\n상각후원가측정 금융자산 처분손익\n85,086\n61,066\n76,830\n위험회피회계 파생상품 관련 손익\n25,306\n(67,719)\n(51,735)\n외환거래손익\n414,790\n489,827\n38,322\n순보험손익\n25,351\n(64,242)\n\u3000\n\u3000보험수익\n552,477\n489,170\n\u3000\n\u3000보험서비스비용\n(521,008)\n(543,379)\n\u3000\n\u3000재보험수익\n36,819\n27,113\n\u3000\n\u3000재보험비용\n(42,937)\n(37,146)\n\u3000\n보험 및 재보험 금융손익\n532\n(11,156)\n\u3000\n총영업이익\n12,234,617\n11,272,242\n10,136,871\n신용손실충당금전입액\n(1,550,742)\n(1,187,056)\n(533,218)\n순영업이익\n10,683,875\n10,085,186\n9,603,653\n일반관리비\n(4,408,272)\n(4,256,713)\n(4,050,460)\n기타영업수익\n894,212\n693,199\n1,587,197\n기타영업비용\n(2,476,408)\n(1,833,390)\n(2,509,294)\n영업이익\n4,693,407\n4,688,282\n4,631,096\n영업외손익\n(12,195)\n255,034\n273,829\n\u3000지분법이익\n160,155\n233,166\n130,980\n\u3000기타수익\n240,161\n261,233\n558,348\n\u3000기타비용\n(412,511)\n(239,365)\n(415,499)\n법인세비용차감전순이익\n4,681,212\n4,943,316\n4,904,925\n법인세비용\n(1,212,856)\n(1,303,906)\n(1,323,343)\n연결당기순이익\n3,468,356\n3,639,410\n3,581,582\n기타포괄손익\n531,779\n(786,710)\n62,539\n\u3000후속적으로 당기손익으로 재분류되는 항목\n\u3000\n\u3000\n\u3000\n\u3000\u3000기타포괄손익-공정가치측정채무증권 평가손익\n757,543\n(915,767)\n(405,131)\n\u3000\u3000해외사업장환산외환차이\n73,595\n5,991\n292,027\n\u3000\u3000지분법자본변동\n(5,009)\n(1,366)\n181,108\n\u3000\u3000순투자위험회피평가손익\n(22,096)\n(20,529)\n(40,788)\n\u3000\u3000현금흐름위험회피평가손익\n(13,907)\n(3,864)\n2,234\n\u3000\u3000특별계정기타포괄손익\n\u3000\n\u3000\n(1,808)\n\u3000\u3000보험계약 관련 금융손익\n(159,752)\n208,279\n\u3000\n\u3000\u3000재보험계약 관련 금융손익\n(352)\n1,953\n\u3000\n\u3000후속적으로 당기손익으로 재분류되지 않는 항목\n\u3000\n\u3000\n\u3000\n\u3000\u3000기타포괄손익-공정가치측정지분증권 평가손익\n79,375\n(56,142)\n18,208\n\u3000\u3000당기손익-공정가치측정항목지정 금융부채신용위험변동효과\n(7,567)\n(7,675)\n(10,356)\n\u3000\u3000공정가치위험회피수단평가손익\n\u3000\n(11,861)\n(14,138)\n\u3000\u3000지분법자본변동\n(1,934)\n(14,676)\n1,534\n\u3000\u3000확정급여제도의 재측정요소\n(168,117)\n28,947\n39,649\n연결당기총포괄이익\n4,000,135\n2,852,700\n3,644,121\n연결당기순이익의 귀속\n\u3000\n\u3000\n\u3000\n\u3000지배기업소유주지분\n3,421,712\n3,570,607\n3,526,068\n\u3000비지배지분\n46,644\n68,803\n55,514\n연결당기총포괄이익의 귀속\n\u3000\n\u3000\n\u3000\n\u3000지배기업소유주지분\n3,944,640\n2,794,791\n3,570,890\n\u3000비지배지분\n55,495\n57,909\n73,231\n주당이익(손실)\n\u3000\n\u3000\n\u3000\n\u3000기본주당이익 (단위 : 원)\n11,380\n11,865\n11,819\n\u3000희석주당이익 (단위 : 원)\n11,380\n11,865\n11,819\n(주1) 2023년 1월 1일부터 국제보험회계기준 IFRS17을 최초 적용함에 따라 제18(전)기 연결재무제표는 재작성되었습니다. 전환일은 2022년 1월 1일 입니다. 구체적인 내용은 III. 재무에 관한 사항 8. 기타 재무에 관한 사항 ""가. 재무제표 재작성 등 유의사항""을 참고하시기 바랍니다.\n(주2) 제17(전전)기 연결재무제표는 IFRS17을 미적용한 금액입니다.\n(주3) 제19기(당기) 재무제표는 주주총회 승인전 재무제표이며, 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.\n2-3. 연결 자본변동표\n연결 자본변동표\n제 19 기 2023.01.01 부터 2023.12.31 까지\n제 18 기 2022.01.01 부터 2022.12.31 까지\n제 17 기 2021.01.01 부터 2021.12.31 까지\n(단위 : 백만원)\n\u3000\n총자본\n지배주주 지분\n비지배지분\n총자본 합계\n자본금\n신종자본증권\n연결자본잉여금\n연결자본조정\n기타포괄손익누계액\n연결이익잉여금\n지배주주 지분 합계\n2021.01.01 (기초자본)\n1,501,210\n2,007,927\n10,579,945\n(315,030)\n(1,001,953)\n17,941,584\n30,713,683\n886,605\n31,600,288\n회계변경 누적효과\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n회계정책변경 후 기초자본\n1,501,210\n2,007,927\n10,579,945\n(315,030)\n(1,001,953)\n17,941,584\n30,713,683\n886,605\n31,600,288\n연차배당\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n(393,611)\n(393,611)\n\u3000\n(393,611)\n중간배당\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n(204,094)\n(204,094)\n\u3000\n(204,094)\n신종자본증권 발행\n\u3000\n618,532\n\u3000\n\u3000\n\u3000\n\u3000\n618,532\n353,739\n972,271\n신종자본증권 상환\n\u3000\n\u3000\n(165)\n\u3000\n\u3000\n\u3000\n(165)\n(29,835)\n(30,000)\n종속회사의 유상증자\n\u3000\n\u3000\n(3,109)\n(578)\n\u3000\n\u3000\n(3,687)\n17\n(3,670)\n종속회사의 지분변동\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n12,889\n12,889\n신종자본증권 배당\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n(80,083)\n(80,083)\n(15,941)\n(96,024)\n자기주식의 소각\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n자기주식의 취득\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n기타포괄손익-공정가치측정 지분증권 이익잉여금 재분류\n\u3000\n\u3000\n\u3000\n\u3000\n(37,096)\n37,096\n\u3000\n\u3000\n\u3000\n기타\n\u3000\n\u3000\n(84)\n2\n\u3000\n(2,748)\n(2,830)\n\u3000\n(2,830)\n소계\n1,501,210\n2,626,459\n10,576,587\n(315,606)\n(1,039,049)\n17,298,144\n30,647,745\n1,207,474\n31,855,219\n연결당기순이익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n3,526,068\n3,526,068\n55,514\n3,581,582\n기타포괄손익-공정가치측정채무증권 평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n(404,332)\n\u3000\n(404,332)\n(799)\n(405,131)\n기타포괄손익-공정가치측정지분증권 평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n18,172\n\u3000\n18,172\n36\n18,208\n해외사업장환산외환차이\n\u3000\n\u3000\n\u3000\n\u3000\n274,147\n\u3000\n274,147\n17,880\n292,027\n지분법자본변동\n\u3000\n\u3000\n\u3000\n\u3000\n182,658\n\u3000\n182,658\n(16)\n182,642\n순투자위험회피평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n(40,788)\n\u3000\n(40,788)\n\u3000\n(40,788)\n현금흐름위험회피평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n1,899\n\u3000\n1,899\n335\n2,234\n공정가치위험회피수단평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n(14,138)\n\u3000\n(14,138)\n\u3000\n(14,138)\n특별계정기타포괄손익\n\u3000\n\u3000\n\u3000\n\u3000\n(1,808)\n\u3000\n(1,808)\n\u3000\n(1,808)\n당기손익-공정가치측정항목지정 금융부채신용위험변동효과\n\u3000\n\u3000\n\u3000\n\u3000\n(10,356)\n\u3000\n(10,356)\n\u3000\n(10,356)\n확정급여제도의 재측정요소\n\u3000\n\u3000\n\u3000\n\u3000\n39,368\n\u3000\n39,368\n281\n39,649\n보험계약 관련 금융손익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n재보험계약 관련 금융손익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n연결당기총포괄이익\n\u3000\n\u3000\n\u3000\n\u3000\n44,822\n3,526,068\n3,570,890\n73,231\n3,644,121\n2021.12.31 (기말자본)\n1,501,210\n2,626,459\n10,576,587\n(315,606)\n(994,227)\n20,824,212\n34,218,635\n1,280,705\n35,499,340\n2022.01.01 (기초자본)\n1,501,210\n2,626,459\n10,576,587\n(315,606)\n(994,227)\n20,824,212\n34,218,635\n1,280,705\n35,499,340\n회계변경 누적효과\n\u3000\n\u3000\n\u3000\n\u3000\n6,810\n(26,981)\n(20,171)\n\u3000\n(20,171)\n회계정책변경 후 기초자본\n1,501,210\n2,626,459\n10,576,587\n(315,606)\n(987,417)\n20,797,231\n34,198,464\n1,280,705\n35,479,169\n연차배당\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n(699,752)\n(699,752)\n\u3000\n(699,752)\n중간배당\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n(233,251)\n(233,251)\n\u3000\n(233,251)\n신종자본증권 발행\n\u3000\n668,229\n\u3000\n\u3000\n\u3000\n\u3000\n668,229\n\u3000\n668,229\n신종자본증권 상환\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n종속회사의 유상증자\n\u3000\n\u3000\n4,905\n\u3000\n44\n\u3000\n4,949\n8,299\n13,248\n종속회사의 지분변동\n\u3000\n\u3000\n(201)\n\u3000\n\u3000\n\u3000\n(201)\n(325,082)\n(325,283)\n신종자본증권 배당\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n(111,210)\n(111,210)\n(29,395)\n(140,605)\n자기주식의 소각\n\u3000\n\u3000\n\u3000\n149,972\n\u3000\n(149,972)\n\u3000\n\u3000\n\u3000\n자기주식의 취득\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n기타포괄손익-공정가치측정 지분증권 이익잉여금 재분류\n\u3000\n\u3000\n\u3000\n\u3000\n225\n(225)\n\u3000\n\u3000\n\u3000\n기타\n\u3000\n\u3000\n\u3000\n593\n\u3000\n13,100\n13,693\n\u3000\n13,693\n소계\n1,501,210\n3,294,688\n10,581,291\n(165,041)\n(987,148)\n19,615,921\n33,840,921\n934,527\n34,775,448\n연결당기순이익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n3,570,607\n3,570,607\n68,803\n3,639,410\n기타포괄손익-공정가치측정채무증권 평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n(912,602)\n\u3000\n(912,602)\n(3,165)\n(915,767)\n기타포괄손익-공정가치측정지분증권 평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n(56,142)\n\u3000\n(56,142)\n\u3000\n(56,142)\n해외사업장환산외환차이\n\u3000\n\u3000\n\u3000\n\u3000\n13,945\n\u3000\n13,945\n(7,954)\n5,991\n지분법자본변동\n\u3000\n\u3000\n\u3000\n\u3000\n(16,068)\n\u3000\n(16,068)\n26\n(16,042)\n순투자위험회피평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n(20,529)\n\u3000\n(20,529)\n\u3000\n(20,529)\n현금흐름위험회피평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n(4,085)\n\u3000\n(4,085)\n221\n(3,864)\n공정가치위험회피수단평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n(11,861)\n\u3000\n(11,861)\n\u3000\n(11,861)\n특별계정기타포괄손익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n당기손익-공정가치측정항목지정 금융부채신용위험변동효과\n\u3000\n\u3000\n\u3000\n\u3000\n(7,675)\n\u3000\n(7,675)\n\u3000\n(7,675)\n확정급여제도의 재측정요소\n\u3000\n\u3000\n\u3000\n\u3000\n28,969\n\u3000\n28,969\n(22)\n28,947\n보험계약 관련 금융손익\n\u3000\n\u3000\n\u3000\n\u3000\n208,279\n\u3000\n208,279\n\u3000\n208,279\n재보험계약 관련 금융손익\n\u3000\n\u3000\n\u3000\n\u3000\n1,953\n\u3000\n1,953\n\u3000\n1,953\n연결당기총포괄이익\n\u3000\n\u3000\n\u3000\n\u3000\n(775,816)\n3,570,607\n2,794,791\n57,909\n2,852,700\n2022.12.31 (기말자본)\n1,501,210\n3,294,688\n10,581,291\n(165,041)\n(1,762,964)\n23,186,528\n36,635,712\n992,436\n37,628,148\n2023.01.01 (기초자본)\n1,501,210\n3,294,688\n10,581,291\n(165,041)\n(1,762,964)\n23,186,528\n36,635,712\n992,436\n37,628,148\n회계변경 누적효과\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n회계정책변경 후 기초자본\n1,501,210\n3,294,688\n10,581,291\n(165,041)\n(1,762,964)\n23,186,528\n36,635,712\n992,436\n37,628,148\n연차배당\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n(743,487)\n(743,487)\n\u3000\n(743,487)\n중간배당\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n(519,028)\n(519,028)\n\u3000\n(519,028)\n신종자본증권 발행\n\u3000\n798,031\n\u3000\n\u3000\n\u3000\n\u3000\n798,031\n\u3000\n798,031\n신종자본증권 상환\n\u3000\n(486,671)\n\u3000\n(1,592)\n\u3000\n\u3000\n(488,263)\n(179,737)\n(668,000)\n종속회사의 유상증자\n\u3000\n\u3000\n1,483\n\u3000\n\u3000\n\u3000\n1,483\n2,479\n3,962\n종속회사의 지분변동\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n신종자본증권 배당\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n(135,526)\n(135,526)\n(32,271)\n(167,797)\n자기주식의 소각\n\u3000\n\u3000\n\u3000\n134,923\n\u3000\n(134,923)\n\u3000\n\u3000\n\u3000\n자기주식의 취득\n\u3000\n\u3000\n\u3000\n(150,000)\n\u3000\n\u3000\n(150,000)\n\u3000\n(150,000)\n기타포괄손익-공정가치측정 지분증권 이익잉여금 재분류\n\u3000\n\u3000\n\u3000\n\u3000\n(51,141)\n51,141\n\u3000\n\u3000\n\u3000\n기타\n\u3000\n\u3000\n\u3000\n28\n\u3000\n(272)\n(244)\n(3)\n(247)\n소계\n1,501,210\n3,606,048\n10,582,774\n(181,682)\n(1,814,105)\n21,704,433\n35,398,678\n782,904\n36,181,582\n연결당기순이익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n3,421,712\n3,421,712\n46,644\n3,468,356\n기타포괄손익-공정가치측정채무증권 평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n757,429\n\u3000\n757,429\n114\n757,543\n기타포괄손익-공정가치측정지분증권 평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n79,375\n\u3000\n79,375\n\u3000\n79,375\n해외사업장환산외환차이\n\u3000\n\u3000\n\u3000\n\u3000\n64,970\n\u3000\n64,970\n8,625\n73,595\n지분법자본변동\n\u3000\n\u3000\n\u3000\n\u3000\n(6,943)\n\u3000\n(6,943)\n\u3000\n(6,943)\n순투자위험회피평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n(22,096)\n\u3000\n(22,096)\n\u3000\n(22,096)\n현금흐름위험회피평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n(13,907)\n\u3000\n(13,907)\n\u3000\n(13,907)\n공정가치위험회피수단평가손익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n특별계정기타포괄손익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n당기손익-공정가치측정항목지정 금융부채신용위험변동효과\n\u3000\n\u3000\n\u3000\n\u3000\n(7,567)\n\u3000\n(7,567)\n\u3000\n(7,567)\n확정급여제도의 재측정요소\n\u3000\n\u3000\n\u3000\n\u3000\n(168,229)\n\u3000\n(168,229)\n112\n(168,117)\n보험계약 관련 금융손익\n\u3000\n\u3000\n\u3000\n\u3000\n(159,752)\n\u3000\n(159,752)\n\u3000\n(159,752)\n재보험계약 관련 금융손익\n\u3000\n\u3000\n\u3000\n\u3000\n(352)\n\u3000\n(352)\n\u3000\n(352)\n연결당기총포괄이익\n\u3000\n\u3000\n\u3000\n\u3000\n522,928\n3,421,712\n3,944,640\n55,495\n4,000,135\n2023.12.31 (기말자본)\n1,501,210\n3,606,048\n10,582,774\n(181,682)\n(1,291,177)\n25,126,145\n39,343,318\n838,399\n40,181,717\n(주1) 2023년 1월 1일부터 국제보험회계기준 IFRS17을 최초 적용함에 따라 제18(전)기 연결재무제표는 재작성되었습니다. 전환일은 2022년 1월 1일 입니다. 구체적인 내용은 III. 재무에 관한 사항 8. 기타 재무에 관한 사항 ""가. 재무제표 재작성 등 유의사항""을 참고하시기 바랍니다.\n(주2) 제19기(당기) 재무제표는 주주총회 승인전 재무제표이며, 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.\n2-4. 연결 현금흐름표\n연결 현금흐름표\n제 19 기 2023.01.01 부터 2023.12.31 까지\n제 18 기 2022.01.01 부터 2022.12.31 까지\n제 17 기 2021.01.01 부터 2021.12.31 까지\n(단위 : 백만원)\n\u3000\n제 19 기\n제 18 기\n제 17 기\n영업활동현금흐름\n\u3000\n\u3000\n\u3000\n\u3000영업활동으로 인한 현금흐름\n(9,622,341)\n25,222,888\n4,929,909\n\u3000\u3000연결당기순이익\n3,468,356\n3,639,410\n3,581,582\n\u3000\u3000당기순이익조정을 위한 가감\n(6,319,050)\n(4,525,099)\n(4,351,479)\n\u3000\u3000\u3000법인세비용\n1,212,856\n1,303,906\n1,323,343\n\u3000\u3000\u3000이자비용\n14,396,495\n6,978,676\n3,430,286\n\u3000\u3000\u3000이자수익\n(23,275,944)\n(15,984,691)\n(10,867,491)\n\u3000\u3000\u3000배당금수익\n(87,731)\n(101,175)\n(66,838)\n\u3000\u3000\u3000당기손익-공정가치측정 금융자산 평가손익\n(1,212,827)\n1,075,049\n277,054\n\u3000\u3000\u3000당기손익-공정가치측정 금융자산 처분손익\n(63,259)\n(32,675)\n(42,913)\n\u3000\u3000\u3000기타포괄손익-공정가치측정 금융자산 거래손익\n(64,172)\n(3,315)\n(93,754)\n\u3000\u3000\u3000기타포괄손익-공정가치측정 금융자산 신용손실 전입(환입)액\n1,841\n(275)\n(64)\n\u3000\u3000\u3000상각후원가측정 금융자산 처분손익\n(232)\n(4)\n\u3000\n\u3000\u3000\u3000상각후원가측정 채무증권관련 신용손실 전입(환입)액\n(36,273)\n66,946\n10,286\n\u3000\u3000\u3000위험회피회계파생상품 관련 손익\n(20,326)\n68,786\n50,561\n\u3000\u3000\u3000외화환산손익\n(106,925)\n(348,998)\n254,606\n\u3000\u3000\u3000신용손실충당금 전입액\n1,585,175\n1,120,385\n522,996\n\u3000\u3000\u3000감가상각비 및 무형자산상각비\n1,219,747\n926,310\n768,787\n\u3000\u3000\u3000주식기준보상비용\n12,282\n21,976\n28,712\n\u3000\u3000\u3000퇴직급여\n158,396\n183,742\n194,874\n\u3000\u3000\u3000지분법이익\n(160,155)\n(233,166)\n(130,980)\n\u3000\u3000\u3000유ㆍ무형자산 관련 기타손익\n32,163\n(5,278)\n(62,272)\n\u3000\u3000\u3000매각예정비유동자산 처분손익\n(568)\n\u3000\n\u3000\n\u3000\u3000\u3000보험관련손익\n(25,883)\n75,398\n\u3000\n\u3000\u3000\u3000기타손익\n116,290\n363,304\n51,328\n\u3000\u3000영업활동으로 인한 자산 부채의 변동\n(16,086,422)\n17,582,246\n(107,019)\n\u3000\u3000\u3000예치금\n1,201,980\n(1,701,892)\n(527,362)\n\u3000\u3000\u3000당기손익-공정가치측정금융자산(단기매매목적)\n(123,838)\n(12,442,233)\n4,638,039\n\u3000\u3000\u3000상각후원가측정 대출채권\n(14,297,588)\n(19,351,728)\n(23,112,201)\n\u3000\u3000\u3000순확정급여자산\n76,317\n(134,965)\n\u3000\n\u3000\u3000\u3000위험회피회계파생상품자산\n\u3000\n\u3000\n(21,013)\n\u3000\u3000\u3000관계기업투자 및 공동기업 투자주식(배당관련)\n65,928\n47,465\n23,201\n\u3000\u3000\u3000보험계약자산\n(4,892)\n(2,071)\n\u3000\n\u3000\u3000\u3000재보험계약자산\n(15,118)\n(13,823)\n\u3000\n\u3000\u3000\u3000기타자산\n(5,524,492)\n1,886,395\n(2,849,831)\n\u3000\u3000\u3000당기손익-공정가치측정 금융부채\n(6,784,956)\n12,957,615\n(4,657,581)\n\u3000\u3000\u3000예수부채\n4,062,161\n32,936,503\n24,942,466\n\u3000\u3000\u3000위험회피회계파생상품부채\n\u3000\n\u3000\n(20,857)\n\u3000\u3000\u3000순확정급여부채\n(221,382)\n(331,043)\n(268,397)\n\u3000\u3000\u3000충당부채\n4,818\n21,420\n29,918\n\u3000\u3000\u3000보험계약부채\n(26,214)\n4,237\n\u3000\n\u3000\u3000\u3000재보험계약부채\n(73)\n(95)\n\u3000\n\u3000\u3000\u3000기타부채\n5,478,321\n3,700,274\n1,716,599\n\u3000\u3000\u3000위험회피목적 파생상품의 순증감\n22,606\n6,187\n\u3000\n\u3000\u3000이자의 수취\n22,923,611\n15,504,156\n10,374,289\n\u3000\u3000배당금의 수취\n87,792\n101,806\n67,258\n\u3000\u3000이자의 지급\n(12,086,823)\n(5,555,400)\n(3,530,628)\n\u3000\u3000법인세의 납부\n(1,609,805)\n(1,524,231)\n(1,104,094)\n투자활동현금흐름\n\u3000\n\u3000\n\u3000\n\u3000투자활동으로 인한 현금흐름\n(5,926,999)\n(18,704,935)\n(8,931,994)\n\u3000\u3000위험회피회계 파생상품의 순증감\n(21,361)\n(11,498)\n\u3000\n\u3000\u3000종속기업의 취득 및 처분으로 인한 순현금흐름\n(761,731)\n121,520\n40,612\n\u3000\u3000당기손익-공정가치측정 금융상품 취득(단기매매목적 외)\n(12,626,273)\n(17,677,402)\n(16,707,654)\n\u3000\u3000당기손익-공정가치측정 금융상품 처분(단기매매목적 외)\n12,830,747\n16,230,662\n17,005,226\n\u3000\u3000기타포괄손익-공정가치측정 금융자산의 취득\n(22,461,365)\n(12,068,581)\n(21,648,517)\n\u3000\u3000기타포괄손익-공정가치측정 금융자산의 처분\n18,026,350\n13,113,422\n18,462,270\n\u3000\u3000상각후원가측정 금융자산의 취득\n(1,248,227)\n(16,822,097)\n(10,511,761)\n\u3000\u3000상각후원가측정 금융자산의 상환\n2,772,528\n1,768,506\n5,429,969\n\u3000\u3000관계기업 투자주식의 취득\n(202,708)\n(633,803)\n(402,667)\n\u3000\u3000관계기업 투자주식의 처분\n95,630\n237,806\n357,122\n\u3000\u3000유형자산의 취득\n(2,177,689)\n(2,458,635)\n(1,163,853)\n\u3000\u3000유형자산의 처분\n121,063\n189,121\n359,175\n\u3000\u3000투자부동산의 취득\n(61,112)\n(449,462)\n(171,986)\n\u3000\u3000투자부동산의 처분\n2,550\n19,998\n127,847\n\u3000\u3000무형자산의 취득\n(236,591)\n(308,773)\n(201,443)\n\u3000\u3000무형자산의 처분\n3,156\n260\n9,122\n\u3000\u3000매각예정비유동자산의 순증감\n36,417\n9,275\n16,147\n\u3000\u3000보증금의 순증감\n(18,383)\n34,746\n68,397\n재무활동현금흐름\n\u3000\n\u3000\n\u3000\n\u3000재무활동으로 인한 현금흐름\n5,677,186\n6,538,185\n6,872,426\n\u3000\u3000위험회피회계 파생상품의 순증감\n13,433\n\u3000\n8,929\n\u3000\u3000차입부채의 순증감\n5,395,440\n6,082,331\n2,827,521\n\u3000\u3000사채의 발행\n36,910,141\n38,261,070\n39,441,225\n\u3000\u3000사채의 상환\n(35,440,925)\n(36,938,979)\n(35,425,612)\n\u3000\u3000리스부채의 상환\n(235,982)\n(223,276)\n(224,509)\n\u3000\u3000자기주식의 취득\n(150,000)\n\u3000\n\u3000\n\u3000\u3000배당금의 지급\n(1,262,515)\n(933,003)\n(597,705)\n\u3000\u3000신종자본증권 발행\n798,031\n668,229\n618,532\n\u3000\u3000신종자본증권 배당\n(135,526)\n(111,210)\n(80,083)\n\u3000\u3000신종자본증권 상환\n(488,263)\n\u3000\n\u3000\n\u3000\u3000비지배지분의 순증감\n273,352\n(266,977)\n304,128\n현금및현금성자산에대한환율변동효과\n\u3000\n\u3000\n\u3000\n\u3000외화표시 현금 및 현금성자산에 대한 환율변동효과\n(219,752)\n(399,427)\n644,916\n현금및현금성자산의 순증감\n(10,091,906)\n12,656,711\n3,515,257\n기초의 현금및현금성자산\n39,728,616\n27,071,905\n23,421,212\n기말의 현금및현금성자산\n29,636,710\n39,728,616\n26,936,469\n(주1) 2023년 1월 1일부터 국제보험회계기준 IFRS17을 최초 적용함에 따라 제18(전)기 연결재무제표는 재작성되었습니다. 전환일은 2022년 1월 1일 입니다. 구체적인 내용은 III. 재무에 관한 사항 8. 기타 재무에 관한 사항 ""가. 재무제표 재작성 등 유의사항""을 참고하시기 바랍니다.\n(주2) 제17(전전)기 연결재무제표는 IFRS17을 미적용한 금액입니다.\n(주3) 제19기(당기) 재무제표는 주주총회 승인전 재무제표이며, 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.\n']"
